» Go to news main
Molly Appeal paves the way to precision cancer treatment
Posted by Melanie Jollymore on
November 24, 2017
in
News
2017 Molly Appeal lead researchers (left to right) Wenda Greer, Zhaolin Xu and Paola Marignani. (Group photos by Danny Abriel; additional photos courtesy Dalhousie Medical Research Foundation)
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- Canadian study published in NEJM could change care after joint replacement surgery
- How Dalhousie researchers are uncovering the hidden links between metabolism, obesity, and heart disease
- How Dr. Christopher McMaster is helping bridge the gap between scientific discovery and patient care
- Why some children develop persistent Lyme arthritis and how to improve care
- Understanding how nutrition can support cardiovascular health as we age
- Dr. Jennifer Johnston is reimagining reproductive health
- Fostering the next generation
- How two Dalhousie alum are helping transform cardiac rhythm care around the world